Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and spread of infectious diseases. However, the full extent of this worrying development is still insufficiently investigated. In a study from 2022, researchers analysed the literature and found […]
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless
Notification EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition to the assays for the detection of antibodies against SARS-CoV-2 (ELISA). The new test is a real-time reverse transcriptase PCR used to detect the genetic material
Press release EUROIMMUN AG (Lübeck, Germany), a manufacturer of reagents and instruments for medical laboratory diagnostics, has developed serological tests for detection of antibodies against the novel coronavirus SARS-CoV-2. The two ELISAs enable detection of specific IgA and IgG against the virus in the blood of infected patients. In December 2019 the WHO in China
It all started at a market in Wuhan, China. Within a few weeks, a novel coronavirus, now called 2019-nCoV, spread to at least 15 regions or countries outside of the Chinese mainland. In December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown aetiology (unknown cause) detected in Wuhan City,
